Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Yoshinori Fujita"'
Autor:
Taeko Fukutani, Yukio Yoshioka, Shinpei Imori, Hirokazu Yanagihara, Kensaku Sumi, Yoshinari Myoken, Yoshinori Fujita, Souichi Yanamoto
Publikováno v:
BMC Oral Health, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Episil® is a nonabsorbable liquid medical material used to coat and protect the mucosa in patients with oral mucositis. A few studies have reported its efficacy in patients with head and neck cancer. However, reports on its use i
Externí odkaz:
https://doaj.org/article/c6a36724566d4ac6824c10849fbf8879
Publikováno v:
Journal of Dental Sciences, Vol 17, Iss 2, Pp 1066-1068 (2022)
Externí odkaz:
https://doaj.org/article/ddb751e5932b4c5b95605d47db267e76
Publikováno v:
Journal of Dental Sciences, Vol 16, Iss 4, Pp 1305-1307 (2021)
Externí odkaz:
https://doaj.org/article/20624e623e264265be7a593d57b0add2
Publikováno v:
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 35:353-357
Autor:
Fumiaki Sanuki, Yuka Mikami, Hirotake Nishimura, Yoshinori Fujita, Yasumasa Monobe, Tsunehisa Nomura, Naruto Taira, TAKUYA MORIYA
Background: B7-H4 and indoleamine 2,3-dioxygenase (IDO1) are factors involved in the inhibition of antitumor activity and are new therapeutic targets for immune checkpoint therapy. However, the category of patients wherein these factors are highly ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a96791d2921d7a3801a8a2780ded66d3
https://doi.org/10.21203/rs.3.rs-2955380/v1
https://doi.org/10.21203/rs.3.rs-2955380/v1
Autor:
Yoshinori Fujita, Yujiro Fukuda, Fumiaki Sanuki, Isao Irei, Yasumasa Monobe, Masako Uno, Takeshi Akisada, Koichiro Shimoya, Hirotaka Hara, Takuya Moriya
Background: Human papillomavirus (HPV)-associated oropharyngeal cancer occasionally has a poor prognosis, making prognostic risk stratification crucial. Protease-activated receptor-1 (PAR1) is involved in carcinogenesis and is regulated by alpha-arre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::435d017c445f20086e79399344ec47b1
https://doi.org/10.21203/rs.3.rs-2967116/v1
https://doi.org/10.21203/rs.3.rs-2967116/v1
Autor:
Masako Nakata, Yoshinori Fujita, Shigeaki Toratani, Yoshiko Myoken, Yoshinari Myoken, Takeshi Kawamoto
Publikováno v:
International Journal of Oral-Medical Sciences. 20:152-156
Bosutinib-induced osteonecrosis of the jaw in a patient with chronic myeloid leukemia: a case report
Publikováno v:
Oral and Maxillofacial Surgery. 25:421-425
Medication-related osteonecrosis of the jaw (MRONJ) is an uncommon adverse drug reaction that can be induced by certain therapeutic drugs, including antiresorptive and antiangiogenic agents. Here, we describe the first case of ONJ induced by bosutini
Publikováno v:
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 32:212-215
Stage 3 medication-related osteonecrosis of the jaw (MRONJ) requires surgical treatment for resolution of the pathology. In the maxilla, removal of the necrotic bone and infected soft tissue leads to large defects with oroantral communications. It is
Autor:
Yoshinari Myoken, Yoshinori Fujita
Publikováno v:
Journal of Japanese Society of Oral Oncology. 32:15-21